Cipher Capital’s Biogen BIIB Stock Holding History

Cipher Capital’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-1,082	Closed	-$301K	–	520
2023 Q1	$301K	Buy	1,082 +154	+17%	+$42.6K	0.06%	397
2022 Q4	$257K	Buy	+928	New	+$262K	0.05%	407

Other funds holding BIIB

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Cipher Capital's BIIB Position: Q2 2023 in Review

Cipher Capital sold out of Biogen (BIIB) in Q2 2023, closing a stake of 1,082 shares — an estimated $301K sold.

Cipher Capital first reported a position in BIIB in Q4 2022 and held it in 2 quarters. The position peaked at $301K in Q1 2023. 1,008 funds tracked by Wall St. Rank hold BIIB as of Q2 2023.

Cipher Capital reported no remaining Biogen position as of Q2 2023 after selling out during the quarter.
Cipher Capital sold 1,082 Biogen shares in Q2 2023, an estimated $301K.
Cipher Capital first reported a position in Biogen in Q4 2022 and held it in 2 quarters.
Cipher Capital's Biogen position peaked at $301K in Q1 2023.
1,008 funds tracked by Wall St. Rank held Biogen as of Q2 2023.

Based on Cipher Capital's 13F filing for Q2 2023, filed 14 Aug 2023.